Memorial Sloan Kettering Cancer Center: Lymphoma, T-Cell trials

The registry lists 10 Lymphoma, T-Cell studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 2 are open to participants now and 2 have results posted.

Phase 1 5Phase 2 5No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Registry for People With T-cell LymphomaRecruitingNCT05978141
• A Study of Ruxolitinib and Duvelisib in People With LymphomaRecruitingNCT05010005Phase 1
• Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell LymphomasCompletedNCT02341014Phase 1/2Results posted
• Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell LymphomaCompletedNCT00255801Phase 2Results posted
• A Study of Enasidenib in People With T-Cell LymphomaActive, not recruitingNCT06756308Phase 2
• A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell TransplantActive, not recruitingNCT05540340Phase 1
• Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell LymphomasCompletedNCT02783625Phase 1
• Study of Ibrutinib in Relapsed and Refractory T-cell LymphomaCompletedNCT02309580Phase 1
• A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin LymphomaCompletedNCT01908777Phase 2
• Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell LymphomaCompletedNCT00030849Phase 2